Skip to main content
Combination of vedolizumab, corticosteroids may improve Crohn's outcomes
1/9/2019

Patients with Crohn's disease treated with vedolizumab and corticosteroids had better remission rates than patients treated with corticosteroids alone, according to a study published in Inflammatory Bowel Diseases. Additional research is needed to see if the benefits continue after patients are switched to maintenance therapy, wrote Dr. Bruce Sands of the Icahn School of Medicine at Mount Sinai and colleagues.

Full Story: